If you want to know who really controls InMode Ltd. (NASDAQ:INMD), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are institutions ...

InMode Ltd. remains a global leader in minimally invasive aesthetic medical devices, trading at a deep discount with a net cash position covering 58% of market cap. Despite a sharp 85% drawdown since ...

Canaccord lowered the firm’s price target on InMode (INMD) to $15 from $16 and keeps a Hold rating on the shares. The firm said they are bullish on the Med-Tech sector heading into 2026 as they expect ...

The latest update is out from InMode ( (INMD)). On November 5, 2025, InMode Ltd. announced its financial results for the third quarter of 2025, reporting revenues of $93.2 million, a decrease from ...

Tap into the wealth of resources you’ll need—getting started is easy Lisa Smith is a writer with a passion for financial journalism, contributing to popular media outlets like Investopedia and ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...